Cas­sava's prob­lems just got much worse as SEC launch­es probe in­to da­ta ma­nip­u­la­tion claims — re­port

The US Se­cu­ri­ties and Ex­change Com­mis­sion has launched a probe in­to claims that Cas­sa­va Sci­ences, an Austin-based drug de­vel­op­er, ma­nip­u­lat­ed da­ta key to its case …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER